Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma

Leuk Lymphoma. 2022 Apr;63(4):768-770. doi: 10.1080/10428194.2022.2027404. Epub 2022 Jan 12.

Authors

Jan-Michel Heger^{1

2

3}, Sven Borchmann^{1

2

3}

Affiliations

¹ Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Cologne, Germany.
² Cologne Lymphoma Working Group, Cologne, Germany.
³ Cancer Center Cologne Essen (CCCE), Cologne, Germany.

PMID: 35021930
DOI: 10.1080/10428194.2022.2027404

No abstract available

Publication types

Comment

MeSH terms

Biomarkers, Tumor / genetics
Circulating Tumor DNA* / genetics
Humans
Lymphoma* / diagnosis
Lymphoma* / genetics

Substances

Biomarkers, Tumor
Circulating Tumor DNA